The US Army Medical Research Acquisition Activity (USAMRAA) intends to award to the University of Massachusetts Medical School for on-going research of clinical phenotype and immunopathogenesis of militarily relevant respiratory pathogens to support medical countermeasure development.
The UMass Medical School was a prominent intellectual contributor to on-going testing plans and aided in development of the original hypothesis that initiated the testing. The samples involved in the testing are in context of a collaborative relationship between the University of Massachusetts Medical School and the Walter Reed Army Institute of Research codified in a CRADA making them part owners of the samples and requiring their concurrence for use.
The contract action is available under Solicitation Number: W81XWH12T0313.
